Wnt/β-catenin pathway
The Wnt/β-catenin pathway is a conserved cell-Signaling cascade that regulates embryonic development, tissue homeostasis, stem cell behavior, and cell fate decisions.
The Wnt/β-catenin pathway is a conserved cell-Signaling cascade that regulates embryonic development, tissue homeostasis, stem cell behavior, and cell fate decisions. In the canonical pathway, Wnt ligand stimulation stabilizes β-catenin, allowing it to accumulate and translocate to the nucleus, where it cooperates with transcriptional regulators such as TCF4 to drive expression of target genes including CCND1 and MYC proto-oncogene (MYC). When the pathway is not appropriately controlled, β-catenin signaling can become aberrantly activated and contribute to tumorigenesis, altered differentiation, fibrosis, and other disease processes.
In biomedical research, the pathway is frequently studied as both a mechanistic node and a therapeutic target. Recent studies in colorectal cancer, lung adenocarcinoma, breast cancer, skeletal aging, and fibrosis-associated models have examined how modulation of Wnt/β-catenin signaling intersects with inflammatory signaling, oxidative stress, ferroptosis, ER stress, ciliogenesis, and drug resistance. The pathway is also relevant in bone biology, where Wnt signaling supports bone health and inhibitors such as Sclerostin can influence skeletal deterioration.
Where the papers sit
11 papers from the last 6 months study wnt/β-catenin pathway directly · updated from PubMed 7 Nov 2026
Study type 0 clinical trials · 8 preclinical · 3 unclassified
Themes 3 themes
-
Wnt-Related Disease Biology
Wnt/β-catenin modulation is being explored across drug resistance, tumor progression, metabolism, and skeletal aging rather than one unified disease program. In colorectal cancer, pathway inhibition is used to resensitize 5-fluorouracil-resistant cells, while Polyphyllin II suppresses thyroid cancer progression through HRH1-linked signaling. Other work connects Wnt networks with hepatitis B virus-associated hepatocellular carcinoma, adzuki bean saponin’s anti-obesity effects, and microRNA regulation of skeletal aging. The shared emphasis is pathway-associated biomarkers and interventions, but the disease contexts and endpoints do not support a single direction.
6 papers · 54.5%
-
Wnt-Related Tissue Repair
Wnt-linked interventions are being tested in unrelated tissue-injury and neurodegeneration settings, without a common therapeutic trajectory. Electroacupuncture-associated DHCR24 is linked to reduced apoptosis and neuroinflammation after spinal cord injury, while GSK-3β inhibition targets synaptic and mitochondrial dysfunction in an Alzheimer’s-like model. A separate nanoparticle formulation delivers honokiol to remodel the hair-follicle microenvironment. These studies share pathway modulation and tissue protection, but their diseases, interventions, and endpoints remain distinct.
3 papers · 27.3%
-
Wnt-Driven Bone Regeneration
Biomaterial-assisted Wnt/β-catenin signaling is being directed toward osteogenic repair in osteoporosis and critical-sized bone defects. β-TCP/PMMA bone cement promotes osteogenic differentiation of osteoporotic bone-marrow stromal cells, with BMP2 and SP7 marking the regenerative program. A Mg-loaded scaffold instead emphasizes microenvironment reprogramming to accelerate defect repair. The shared direction is local, osteogenic tissue engineering, while the relative contribution of ion release, scaffold architecture, and Wnt signaling remains open.
2 papers · 18.2%
Papers
The 11 papers from the last 6 months that study wnt/β-catenin pathway directly, newest first, by theme and by study type. Study types come from PubMed publication types and MeSH headings.
By theme
Wnt-Related Disease Biology (6)
- Pharmacological inhibition of the canonical Wnt/β-catenin signaling pathway sensitizes 5-fluorouracil-resistant colorectal cancer cells. Molecular biology reports · 4 Sept 2026 PMID 42696229
- All-trans retinoic acid suppresses CD8+ T-cell terminal exhaustion and potentiates anti-PD-1 therapy in glioblastoma. Signal transduction and targeted therapy · 25 Aug 2026 PMID 42642387
- Polyphyllin II inhibits thyroid cancer progression by targeting HRH1 and suppressing Wnt/β‑catenin signaling. Oncology reports · 24 Jul 2026 PMID 42495777
- Anti-obesity mechanisms of adzuki bean saponin: a multi-omics and experimental study. NPJ science of food · 5 Jun 2026 PMID 42248912
- Comprehensive multi-omics analysis identifies cancer subtypes and prognostic signatures of hepatitis B virus-associated hepatocellular carcinoma. NPJ precision oncology · 4 Jun 2026 PMID 42243437
- MicroRNA networks associated with skeletal aging and WNT pathway modulation. Calcified tissue international · 25 May 2026 PMID 42183846
Wnt-Related Tissue Repair (3)
- Electroacupuncture-modulated DHCR24 facilitates spinal cord injury recovery by attenuating apoptosis and neuroinflammation via the Wnt signaling pathway. Metabolic brain disease · 2 Jul 2026 PMID 42390651
- Ionic liquid-coated Eudragit RS nanoparticles for topical delivery of honokiol to remodel the hair follicle microenvironment in androgenic alopecia. International journal of pharmaceutics · 17 Jun 2026 PMID 42309201
- Glycogen Synthase Kinase-3β Inhibition Ameliorates Synaptic and Mitochondrial Dysfunction in a Sporadic Alzheimer's Disease-Like Model. Molecular neurobiology · 17 Jun 2026 PMID 42307791
Wnt-Driven Bone Regeneration (2)
- A β-TCP/PMMA composite bone cement promotes osteogenic differentiation of osteoporotic rBMSCs via Wnt/β-catenin pathway. 3 Biotech · 9 Aug 2026 PMID 42571078
- Flowerbed-Inspired Mg-Loaded Scaffold Accelerates Critical-Sized Bone-Defect Repair by Reprogramming the Microenvironment. ACS nano · 28 May 2026 PMID 42204979
By study type
Preclinical: animal, cell and lab studies (8)
- Pharmacological inhibition of the canonical Wnt/β-catenin signaling pathway sensitizes 5-fluorouracil-resistant colorectal cancer cells. Molecular biology reports · 4 Sept 2026 PMID 42696229
- All-trans retinoic acid suppresses CD8+ T-cell terminal exhaustion and potentiates anti-PD-1 therapy in glioblastoma. Signal transduction and targeted therapy · 25 Aug 2026 PMID 42642387
- Polyphyllin II inhibits thyroid cancer progression by targeting HRH1 and suppressing Wnt/β‑catenin signaling. Oncology reports · 24 Jul 2026 PMID 42495777
- Electroacupuncture-modulated DHCR24 facilitates spinal cord injury recovery by attenuating apoptosis and neuroinflammation via the Wnt signaling pathway. Metabolic brain disease · 2 Jul 2026 PMID 42390651
- Ionic liquid-coated Eudragit RS nanoparticles for topical delivery of honokiol to remodel the hair follicle microenvironment in androgenic alopecia. International journal of pharmaceutics · 17 Jun 2026 PMID 42309201
- Glycogen Synthase Kinase-3β Inhibition Ameliorates Synaptic and Mitochondrial Dysfunction in a Sporadic Alzheimer's Disease-Like Model. Molecular neurobiology · 17 Jun 2026 PMID 42307791
- Flowerbed-Inspired Mg-Loaded Scaffold Accelerates Critical-Sized Bone-Defect Repair by Reprogramming the Microenvironment. ACS nano · 28 May 2026 PMID 42204979
- MicroRNA networks associated with skeletal aging and WNT pathway modulation. Calcified tissue international · 25 May 2026 PMID 42183846
Unclassified: not yet indexed with MeSH (3)
- A β-TCP/PMMA composite bone cement promotes osteogenic differentiation of osteoporotic rBMSCs via Wnt/β-catenin pathway. 3 Biotech · 9 Aug 2026 PMID 42571078
- Anti-obesity mechanisms of adzuki bean saponin: a multi-omics and experimental study. NPJ science of food · 5 Jun 2026 PMID 42248912
- Comprehensive multi-omics analysis identifies cancer subtypes and prognostic signatures of hepatitis B virus-associated hepatocellular carcinoma. NPJ precision oncology · 4 Jun 2026 PMID 42243437
Written from 11 PubMed abstracts, each one listed by PMID above. Published: 2026-06-15. Last written: 2026-08-26 by GPT. Drafted by language models from published abstracts; not medical advice.